Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

278 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Basal and stimulated inhibin B in pubertal disorders.
Chaudhary S, Walia R, Quinton R. Chaudhary S, et al. Among authors: quinton r. J Clin Endocrinol Metab. 2025 Jan 9:dgaf005. doi: 10.1210/clinem/dgaf005. Online ahead of print. J Clin Endocrinol Metab. 2025. PMID: 39787047
Editorial: Male hypogonadism: need for reclassification?
Cannarella R, Quinton R, Calogero AE. Cannarella R, et al. Among authors: quinton r. Front Endocrinol (Lausanne). 2024 Nov 11;15:1514350. doi: 10.3389/fendo.2024.1514350. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 39588338 Free PMC article. No abstract available.
The effects and safety of testosterone replacement therapy for men with hypogonadism: the TestES evidence synthesis and economic evaluation.
Cruickshank M, Hudson J, Hernández R, Aceves-Martins M, Quinton R, Gillies K, Aucott LS, Kennedy C, Manson P, Oliver N, Wu F, Bhattacharya S, Dhillo WS, Jayasena CN, Brazzelli M. Cruickshank M, et al. Among authors: quinton r. Health Technol Assess. 2024 Aug;28(43):1-210. doi: 10.3310/JRYT3981. Health Technol Assess. 2024. PMID: 39248210 Free PMC article.
Testosterone-induced erythrocytosis in transgender males: Challenges arising from an increasing prevalence of metabolic syndrome and wider therapeutic indications for prescribing SGLT2 inhibitor drugs.
Mohammed A, Mamoojee YH, Quinton R. Mohammed A, et al. Among authors: quinton r. Best Pract Res Clin Endocrinol Metab. 2024 Sep;38(5):101930. doi: 10.1016/j.beem.2024.101930. Epub 2024 Aug 25. Best Pract Res Clin Endocrinol Metab. 2024. PMID: 39198051 Review. No abstract available.
278 results